Open Surgery Instruments – Market Insights – Europe

The European open surgery instrument market has shown recovery from the impact of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent marginal expansion through 2032. Growth over the forecast period will be driven primarily by the continued uptake of innovative, premium-priced products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in Europe from 2019 through 2032.

The number of open surgery procedures performed will contract through 2032.

Which procedure types are seeing a decline, and which ones are increasing?

How will the dynamics across the open surgery procedure types ultimately impact market growth?

What are the forces driving or hampering growth of the various open surgery procedure types in Europe?

The changing shift toward minimally invasive surgeries and robotic-assisted laparoscopy will have an impact on open surgery procedures.

Which procedures will be more or less affected by the shift to MIS and robotic-assisted laparoscopy?

Why are some procedures more affected by this trend than others?

Open surgery instrument competitors are continuing to improve devices in an effort to address existing barriers to adoption and to improve efficacy of treatment despite the general lack of product innovations in some segments of the open surgery instrument market.

What are the new products available in the market?

Which competitor is leading on the innovation front of open surgery instrument market?

Table of contents

Open Surgery Instruments - Market Insights - Europe

Harshada H

Harshada H is an associate healthcare research and data analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in biosurgical agent market. Harshada holds a Bachelor’s degree in Biotechnology, Chemistry and Zoology from Christ University, Bangalore, and a Master’s degree in Science and Technology Communication from CSIR-NIScPR (CSIR-National Institute of Science Communication and Policy Research), New Delhi.

Contact sales Login to access report

Back to all Medtech Insights reports